By invitation only

A new beginning for neurodevelopment disorders: science-based intervention for individual patients

When:
2 October 2019  -  3 October 2019
Where:
KNAW, Trippenhuis, Kloveniersburgwal 29, 1011 JV Amsterdam
Contact:
Phone:
020 551 0767
Add event:

Autism Spectrum Disorder is diagnosed based on generic and subjective criteria. These criteria are insufficient to guide therapy choice and fail to support novel treatment development. Experimental studies indicate efficacy of many existing and novel treatments for subsets of patients, and their successful application requires stratification and mechanistically plausible, objective outcome measures. 

This Academy Colloquium aims to initiate discussions among pioneers on taxonomy revision and translational opportunities for new, rational therapy design.

The meeting will be started by our distinguished keynote lecturer, Prof. Steve Hyman, past chairman of the NIMH and provost of Harvard University and current chairman of the Stanley Center for Psychiatric Research - Broad Institute at MIT. In three subsequent sessions, experts from all over the world will further discuss how genetics, imaging techniques, cellular analyses and clinical triage can be integrated to new science-based care.

Organisation

This colloquium is organised by Professor Matthijs Verhage, PhD (VU University Amsterdam) and Dr Hilgo Bruining, MD (University Medical Center Utrecht).